Venture
Affiliations
Rockefeller University
Technologies
Medical Device
Indication
Allergy/Asthma
Basic Research
Clinical Trials
Metabolic Disease
Neurodegenerative Disease
Obesity
Personalized Medicine
Smell-RS is developing a digital diagnostic device for testing olfactory function, which is an early symptom of neurodegenerative diseases that affect 10% of the population.
Smell-RS Team:
Andreas Keller, CEO